Oxford Health-supported trial finds Parkinson’s drug pramipexole effective for treatment-resistant depression
Posted:
A drug used for Parkinson’s disease has been shown to be effective in reducing the symptoms of difficult to treat depression, in a study led by the University of Oxford.
Sanome has secured Class IIb CE certification and MHRA approval for MEMORI - an AI-enabled warning system for the early prediction/prevention of healthcare‑associated infections (HAIs).
Read more here.
Driven by demand, Conexen are hoping to launch a new community in Manchester this October. They have an amazing team of local executives ready to go and excited to bring everybody in life sciences, biopharma and health together.
Contact them:…
Attendees
Sponsors and Exhibitors
Contact us